Search Results

There are 4195 results for: content related to: rFVII a – for acute rebleeding of a cerebral cavernous malformation

  1. You have free access to this content
    Activity and regulation of glycoPEGylated factor VIIa analogs

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 9, September 2008, Pages: 1525–1533, S. GHOSH, P. SEN, U. R. PENDURTHI and L. V. M. RAO

    Version of Record online : 4 JUL 2008, DOI: 10.1111/j.1538-7836.2008.03065.x

  2. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

    Intervention Review

    The Cochrane Library

    Ewurabena Simpson, Yulia Lin, Simon Stanworth, Janet Birchall, Carolyn Doree and Chris Hyde

    Published Online : 14 MAR 2012, DOI: 10.1002/14651858.CD005011.pub4

  3. Effect of glycoPEGylation on factor VIIa binding and internalization

    Haemophilia

    Volume 16, Issue 2, March 2010, Pages: 339–348, P. SEN, S. GHOSH, M. EZBAN, U. R. PENDURTHI and L. VIJAYA MOHAN RAO

    Version of Record online : 21 OCT 2009, DOI: 10.1111/j.1365-2516.2009.02121.x

  4. Recombinant factor VIIa in paediatric bleeding disorders – a 2006 review

    Haemophilia

    Volume 12, Issue 5, September 2006, Pages: 457–472, P. MATHEW and G. YOUNG

    Version of Record online : 16 OCT 2006, DOI: 10.1111/j.1365-2516.2006.01321.x

  5. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile

    Transfusion

    Volume 46, Issue 6, June 2006, Pages: 919–933, Jerrold H. Levy, Abe Fingerhut, Thomas Brott, Irene H. Langbakke, Elisabeth Erhardtsen and Robert J. Porte

    Version of Record online : 11 APR 2006, DOI: 10.1111/j.1537-2995.2006.00824.x

  6. You have free access to this content
    A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors

    Haemophilia

    Volume 15, Issue 2, March 2009, Pages: 405–419, C. KNIGHT, A. M. DANØ and T. KENNEDY-MARTIN

    Version of Record online : 1 FEB 2009, DOI: 10.1111/j.1365-2516.2008.01969.x

  7. You have free access to this content
    A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation

    British Journal of Haematology

    Volume 138, Issue 1, July 2007, Pages: 82–93, Robert A. Campbell, Thomas H. Fischer and Alisa S. Wolberg

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1365-2141.2007.06617.x

  8. You have free access to this content
    Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers

    British Journal of Haematology

    Volume 124, Issue 5, March 2004, Pages: 653–658, Nick R. Bijsterveld, Roel Vink, Benien E. Van Aken, Hein Fennema, Ron J. G. Peters, Joost C. M. Meijers, Harry R. Büller and Marcel Levi

    Version of Record online : 2 FEB 2004, DOI: 10.1111/j.1365-2141.2003.04811.x

  9. You have full text access to this OnlineOpen article
    The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework

    Transfusion Medicine

    Volume 22, Issue 6, December 2012, Pages: 383–394, Y. Lin, C. J. Moltzan, D. R. Anderson and on behalf of the National Advisory Committee on Blood and Blood Products

    Version of Record online : 27 MAY 2012, DOI: 10.1111/j.1365-3148.2012.01164.x

  10. You have full text access to this OnlineOpen article
    Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 11, November 2012, Pages: 2383–2391, C. A. CLARK, R. VATSYAYAN, U. HEDNER, C. T. ESMON, U. R. PENDURTHI and L. V. M. RAO

    Version of Record online : 30 OCT 2012, DOI: 10.1111/j.1538-7836.2012.04917.x

  11. Use of recombinant activated factor VII in the management of medical and surgical bleeding: a critical review

    Transfusion Alternatives in Transfusion Medicine

    Volume 8, Issue s1, December 2006, Pages: 66–80, MARIE E. STEINER and NIGEL S. KEY

    Version of Record online : 14 NOV 2006, DOI: 10.1111/j.1778-428X.2006.00033.x

  12. Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patients with inhibitors?

    Haemophilia

    Volume 14, Issue s6, November 2008, Pages: 68–81, E. C. RODRIGUEZ-MERCHAN, U. HEDNER, L. HEIJNEN, V. JIMENEZ-YUSTE, C. A. LEE, M. MORFINI, F. QUEROL, G. ROOSENDAAL, E. SANTAGOSTINO and L. P. SOLIMENO

    Version of Record online : 29 SEP 2008, DOI: 10.1111/j.1365-2516.2008.01892.x

  13. Recombinant activated factor VII for trauma patients

    Transfusion Alternatives in Transfusion Medicine

    Volume 8, Issue s1, December 2006, Pages: 20–26, RICHARD P. DUTTON

    Version of Record online : 14 NOV 2006, DOI: 10.1111/j.1778-428X.2006.00027.x

  14. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes

    Transfusion

    Volume 45, Issue 9, September 2005, Pages: 1434–1442, Robert MacLaren, Laura A. Weber, Helga Brake, Melinda A. Gardner and Mario Tanzi

    Version of Record online : 22 JUL 2005, DOI: 10.1111/j.1537-2995.2005.00548.x

  15. You have free access to this content
    Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 4, April 2007, Pages: 774–780, M. KJALKE, S. KJELLEV and R. ROJKJAER

    Version of Record online : 9 JAN 2007, DOI: 10.1111/j.1538-7836.2007.02389.x

  16. You have free access to this content
    Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 10, October 2004, Pages: 1700–1708, L. M. Aledort

    Version of Record online : 28 SEP 2004, DOI: 10.1111/j.1538-7836.2004.00944.x

  17. You have free access to this content
    Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 10, October 2003, Pages: 2175–2178, T. Lisman, P. G. De Groot, T. Lambert, R. Røjkjær and E. Persson

    Version of Record online : 4 SEP 2003, DOI: 10.1046/j.1538-7836.2003.00444.x

  18. You have free access to this content
    Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 6, June 2004, Pages: 899–909, T. Abshire and G. Kenet

    Version of Record online : 11 MAY 2004, DOI: 10.1111/j.1538-7836.2004.00759.x

  19. Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion

    Transfusion

    Volume 52, Issue 8, August 2012, Pages: 1696–1702, Kwok M. Ho and Edward Litton

    Version of Record online : 30 DEC 2011, DOI: 10.1111/j.1537-2995.2011.03505.x

  20. You have free access to this content
    Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A

    British Journal of Haematology

    Volume 137, Issue 2, April 2007, Pages: 158–165, Benny Sørensen, Egon Persson and Jørgen Ingerslev

    Version of Record online : 1 MAR 2007, DOI: 10.1111/j.1365-2141.2007.06534.x